Glaukos Preliminary 2025 Net Sales Rise 32% to $507 Million; 2026 Guidance Reaffirmed
Glaukos said preliminary, unaudited net sales were about $143 million for the fourth quarter of 2025, up 36% year over year, and about $507 million for full-year 2025, up 32%. The company also reaffirmed its 2026 net sales guidance of $600 million to $620 million, and reported about $283 million in cash, cash equivalents, short-term investments and restricted cash with no debt.
Key points
- Q4 2025 preliminary net sales of about $143 million, up 36% from the same period in 2024
- Full-year 2025 preliminary net sales of about $507 million, up 32% from 2024
- 2026 net sales guidance of $600 million to $620 million reaffirmed
- About $283 million in cash and investments at year-end 2025 and no debt; full results due February 17, 2026
The filing
Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 1:12 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on January 13, 2026.
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.